TRIMAS CORPORATION
In the published model solve dated 2026-Q2, anchored at $39.53, TRIMAS CORPORATION (TRS) is priced for -2.2% growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. The narrative was composed July 11, 2026 from SEC EDGAR filings.
• TriMas sold its aerospace business in March 2026 for net proceeds of $1.24 billion, leaving a company with $913 million of net cash against a $1.55 billion market cap and two remaining segments, led by Packaging, which the 10-K reports at ⟦"net sales: $535.5 million; operating profit: $68.1 million"⟧. [Source: Q1 2026 10-Q, April 2026] • The headline numbers mislead in both directions: the trailing P/E near 2x is an artifact of the one-time sale gain, while the real question is whether a mid-s
Is TRS overvalued? See what's priced in →
185 institutional managers reported holding TRS in 13F filings for the quarter ended 2026-03-31. Together they hold about 94% of the company; the top 10 hold 56%. 22 opened new positions that quarter. Held by Vanguard Group, BlackRock, Dimensional Fund Advisors, among others. On the short side, 4.4M shares were sold short as of the 2026-06-15 count, about 12% of shares outstanding (9.2 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
TRS has cut its share count 13.2% over the past five years, spending $237.70M on repurchases. It pays a dividend, and has for 5 years running, raised 2 years straight; the current rate is $0.04 a share annually. Cash returned over the past three years: $18.09M in dividends and $182.81M in repurchases.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
Open-market insider buys at TRS over the trailing three years: 2023: 4 buys totaling $2k; 2024: 13 buys totaling $1.11M; 2025: 25 buys totaling $47.32M; 2026: 1 buy totaling $2k. 15 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
TRS's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-04-28 | +0.4% | +8.2% |
| 2023-07-28 | -2.0% | -9.4% |
| 2023-10-27 | +3.6% | +6.8% |
| 2024-03-01 | -8.5% | +11.6% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
TRS's latest 8-K filings: 2026-07-30 (items 2.02, 9.01); 2026-05-21 (items 5.07); 2026-04-30 (items 2.02, 9.01); 2026-03-18 (items 2.01, 7.01, 9.01); 2026-03-12 (items 5.02, 9.01).
Item codes are the SEC's own classification of what each report discloses. Dates link to the filing on EDGAR. Nothing here is investment advice.
Model solve date: 2026-Q2
Narrative composed: July 11, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.